Annexin A5 (ANXA5) Peptide
ANXA5
适用: 人
宿主: 合成
BP, WB
-
- 抗原 See all Annexin V (ANXA5) products
- Annexin V (ANXA5) (Annexin A5 (ANXA5))
- 宿主
- 人
-
资源
- 合成
- 应用范围
- Blocking Peptide (BP), Western Blotting (WB)
- 产品特性
- This is a synthetic peptide designed for use in combination with anti-ANXA5 antibody (Catalog #: ARP36687_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- 纯化方法
- Purified
-
-
- 应用备注
- Each Investigator should determine their own optimal working dilution for specific applications.
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 溶解方式
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- 浓度
- 1 mg/mL
- 缓冲液
- Final peptide concentration is 1 mg/mL in PBS.
- 注意事项
- Avoid repeated freeze-thaw cycles.
- 储存条件
- -20 °C
- 储存方法
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- 抗原
- Annexin V (ANXA5) (Annexin A5 (ANXA5))
- 背景
-
ANXA5 belongs to the annexin family of calcium-dependent phospholipid binding proteins some of which have been implicated in membrane-related events along exocytotic and endocytotic pathways. Annexin 5 is a phospholipase A2 and protein kinase C inhibitory protein with calcium channel activity and a potential role in cellular signal transduction, inflammation, growth and differentiation. Annexin 5 has also been described as placental anticoagulant protein I, vascular anticoagulant-alpha, endonexin II, lipocortin V, placental protein 4 and anchorin CII. The gene spans 29 kb containing 13 exons, and encodes a single transcript of approximately 1.6 kb and a protein product with a molecular weight of about 35 kDa.
Alias Symbols: PP4, ANX5, ENX2, RPRGL3
Protein Interaction Partner: ACTG1,COL10A1,COL2A1,EED,EIF4G1,FDFT1,IFNGR2,ITGB5,KDR,PPP2R1B,SUPT4H1,COL10A1,COL2A1,EED,FDFT1,ITGB5,KDR
Protein Size: 320 - 分子量
- 35 kDa
- 基因ID
- 308
- NCBI登录号
- NM_001154, NP_001145
- UniProt
- Q6FHB3
-
You are here:
